JAN HIRSCH

Telephone: 858-822-5562

e-mail: jhirsch1@ucsd.edu

 

Dr. Jan Hirsch is a Lecturer in Pharmacy in the UCSD School of Pharmacy and Pharmaceutical Sciences where she is responsible for coursework in Health Policy, Pharmacoeconomics, Study Design and Technology Management. Dr. Hirsch received her BS in Pharmacy in 1980, her MS in Pharmacy Administration in 1983 and her Ph.D. in Pharmacy Administration in 1986 from the University of South Carolina, College of Pharmacy. During her graduate studies, she also worked as a pharmacist in several community pharmacy settings and as a teaching and research assistant at the College of Pharmacy. From 1986-1990, she was an Assistant Professor of Pharmacy Administration at the University of North Carolina School of Pharmacy. From 1990 through 1993, she was Assistant and then Associate Director of Pharmacoeconomic Research for Glaxo, Inc in Research Triangle Park, North Carolina. She then became Head of International Pharmacoeconomic Research for Glaxo Group Research in Greenford, United Kingdom until 1994. In 1994, she started her own pharmacoeconomic consulting group where she managed collaborative research between universities, managed care organizations, physician groups and major pharmaceutical companies. In 1997, she joined Allergan as Director of Global Pharmacoeconomic Strategy and Research.  Most recently she served as Director of Clinical Research at Prescription Solutions where she was responsible for establishing a prospective research function to examine the value of pharmaceuticals within a managed care setting.

 

Book Chapters

 

Hirsch JD, Managing Pharmacoeconomic evaluations in clinical trials. Health Outcomes and Pharmaceutical Care: Measurement, Applications and Initiatives, Pharmaceutical Press, Binghampton, NY, 1996.

 

Johnson N, Hirsch J, Nash D and Schrogie J., Pharmacoeconomics Research in Medical Centers. Principles of Economics, 2nd Edition, Harvey Whiteny Publishers, Cincinnati, OH, 1996.

 

Lindley CM and Hirsch JD, Nausea and Vomiting: Impact on Cancer Patient’s Quality of Life. Quality of Life in Oncology Practice and Research, Dominus Publishing Company, Williston Park, NY, 1991.

 

Hartzema AG, ed; Hirsch JD, Assoc Ed., Pharmaceutical Chartbook, Lewis Publishers, Inc. Boca Raton, FL, 1990.

 

Selected Recent Publications

 

Hirsch JD, Real-world pharmaceutical research improves care, increases satisfaction. Managed Healthcare Executive 2002;12:32-33.

 

Nelson DJ, Helms H, Fiscella R, Southwell Y and Hirsch JD. A new look at dry eye disease and its treatment. Advances in therapy 2000;17:84-93.

 

Schiffman RM, Christianson M, Jacobson G, Hirsch JD and Reis B. Validation of the Ocular Surface Disease index. Archives of Ophthalmology 2000;118:615-621.

 

Hirsch JD and O’Brien TP. Pharmacoeconomics of ocular anti-infective treatments. Ophthalmology Clinics of North America – Ocular Infections: Update on therapy. 1999;12:1-8.

 

Heywood J, Bouchard J, Cortelli P, Dahlof C, Jansen J-P, Pham S, Hirsch J et al. A multinational investigation of the impact of subcutaneous sumatriptan: (I) Design, methods and clinical findings. Pharmcoeconomics 1997;11:11-23.

 

Dahlof C, Boucahard J, Cortelli P, Heywood J, Jensen J-P, Pham S, Hirsch J et al. A multinational investigation of the impact of subcutaneous sumatriptan: (II) Health-related quality of life. Pharmacoeconomics 1997;11:24-34.

 

Cortelli P, Dahlof C, Bouchard J, Heywood J, Jensen J-P, Pham S, Hirsch J et al. A multinational investigation of the impact of subcutaneous sumatriptan: (III) Workplace productivity and non-workplace activity. Pharmacoeconomics 1997;11:35-42.